LTFS
JAZZ icon

Ladenburg Thalmann Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$346K Sell
2,320
-710
-23% -$96.6K ﹤0.01% 2102
2019
Q3 		$389K Buy
3,030
+1,379
+84% +$185K ﹤0.01% 1960
2019
Q2 		$233K Buy
1,651
+595
+56% +$80K ﹤0.01% 2358
2019
Q1 		$150K Sell
1,056
-54
-5% -$7.04K ﹤0.01% 2605
2018
Q4 		$138K Buy
1,110
+105
+10% +$15.6K ﹤0.01% 2520
2018
Q3 		$168K Buy
1,005
+426
+74% +$73.3K ﹤0.01% 2444
2018
Q2 		$86K Hold
579
– – ﹤0.01% 2847
2018
Q1 		$86K Sell
579
-1,391
-71% -$204K ﹤0.01% 2847
2017
Q4 		$265K Buy
1,970
+224
+13% +$31.1K ﹤0.01% 2004
2017
Q3 		$255K Buy
1,746
+1,551
+795% +$235K ﹤0.01% 1917
2017
Q2 		$31K Sell
195
-94
-33% -$14.4K ﹤0.01% 3335
2017
Q1 		$42K Buy
289
+172
+147% +$22.4K ﹤0.01% 3036
2016
Q4 		$13K Sell
117
-628
-84% -$69.9K ﹤0.01% 3734
2016
Q3 		$91K Sell
745
-23
-3% -$3.1K ﹤0.01% 2319
2016
Q2 		$109K Sell
768
-229
-23% -$33.8K ﹤0.01% 2098
2016
Q1 		$130K Sell
997
-161
-14% -$20K ﹤0.01% 1892
2015
Q4 		$163K Buy
1,158
+404
+54% +$56K ﹤0.01% 1717
2015
Q3 		$100K Sell
754
-660
-47% -$114K ﹤0.01% 1987
2015
Q2 		$249K Sell
1,414
-324
-19% -$58.2K ﹤0.01% 1449
2015
Q1 		$300K Sell
1,738
-448
-20% -$76.9K 0.01% 1318
2014
Q4 		$359K Buy
2,186
+486
+29% +$80.7K 0.01% 1093
2014
Q3 		$273K Buy
1,700
+638
+60% +$98.1K 0.01% 1062
2014
Q2 		$156K Sell
1,062
-18
-2% -$2.5K ﹤0.01% 1333
2014
Q1 		$150K Buy
1,080
+39
+4% +$5.87K ﹤0.01% 1276
2013
Q4 		$132K Sell
1,041
-370
-26% -$38.3K ﹤0.01% 1299
2013
Q3 		$130K Buy
1,411
+511
+57% +$41.2K ﹤0.01% 1242
2013
Q2 		$62K Buy
+900
New +$55K ﹤0.01% 1577

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Ladenburg Thalmann Financial Services's JAZZ Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Jazz Pharmaceuticals (JAZZ) stake by 23% in Q4 2019, selling an estimated $96.6K and leaving 2,320 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Ladenburg Thalmann Financial Services first reported a position in JAZZ in Q2 2013 and has held it in 27 quarters since. The position peaked at $389K in Q3 2019. 446 funds tracked by Wall St. Rank hold JAZZ as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2,320 shares of Jazz Pharmaceuticals worth $346K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 710 Jazz Pharmaceuticals shares in Q4 2019, an estimated $96.6K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2102 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Jazz Pharmaceuticals position peaked at $389K in Q3 2019.
  • 446 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.